Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) has a good prognosis compared to ALK-negative ALCL, possibly as a result of the immune recognition of the ALK proteins. The aim of our study was to investigate the presence of both a B and cytotoxic T cell (CTL) response to ALK in ALK-positive ALCL. We confirmed the presence of an antibody response to ALK in all 9 ALK-positive ALCL patients investigated. An ELISpot assay was used to detect a gamma-interferon (IFN) T cell response after short term culture of mononuclear blood cells with 2 ALK-derived HLA-A*0201 restricted peptides: ALKa and ALKb. A significant gamma-IFN response was identified in all 7 HLA-A*0201-positive ALK-positive ALCL patients but not in ALK-negative ALCL patients (n = 2) or normal subjects (n = 6). CTL lines (>95% CD8-positive) raised from 2 ALK-positive ALCL patients lysed ALK-positive ALCL derived cell lines in a MHC-Class I restricted manner. This is the first report of both a B cell and CTL response to ALK in patients with ALK-positive ALCL. This response persisted during long-term remission. The use of modified vaccinia virus Ankara (MVA) to express ALK is also described. Our findings are of potential prognostic value and open up therapeutic options for those ALK-positive patients who do not respond to conventional treatment.

Original publication

DOI

10.1002/ijc.21410

Type

Journal article

Journal

Int J Cancer

Publication Date

01/02/2006

Volume

118

Pages

688 - 695

Keywords

Adolescent, Adult, Child, Child, Preschool, Cytotoxicity, Immunologic, Epitopes, B-Lymphocyte, Epitopes, T-Lymphocyte, Female, HLA-A Antigens, HLA-A2 Antigen, Humans, Interferon-gamma, Lymphoma, Large-Cell, Anaplastic, Male, Middle Aged, Peptide Fragments, Prognosis, Protein-Tyrosine Kinases, Receptor Protein-Tyrosine Kinases, T-Lymphocytes, Cytotoxic, Tumor Cells, Cultured, Vaccinia virus